Chlamydia protein, gene sequence and uses thereof

Details Chlamydia protein, gene sequence and uses thereof Chlamydia protein, gene sequence and uses thereof

2003-11-04

2008-09-02

Ungar, Susan (Department: 1645)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S326000, C435S328000, C435S332000, C536S023700, C530S300000, C530S350000, C530S402000, C530S811000, C530S814000, C530S820000, C530S387100, C424S234100, C424S263100, C424S192100, C424S190100

Reexamination Certificate

active

07419807

ABSTRACT:
A high molecular weight (“HMW”) protein ofChlamydia, the amino acid sequence thereof, and antibodies that specifically bind the HMW protein are disclosed as well as the nucleic acid sequence encoding the same. Also disclosed are prophylactic and therapeutic compositions, comprising the HMW protein, a fragment thereof, or an antibody that specifically binds the HMW protein or a portion thereof, or the nucleotide sequence encoding the HMW protein or a fragment thereof, including vaccines.

REFERENCES:
patent: 4427782 (1984-01-01), Caldwell et al.
patent: 4855283 (1989-08-01), Lockhoff et al.
patent: 4935352 (1990-06-01), Igarashi et al.
patent: 5071962 (1991-12-01), Morrison et al.
patent: 5516638 (1996-05-01), Urnovitz et al.
patent: 5565352 (1996-10-01), Hochstrasser et al.
patent: 5629167 (1997-05-01), Ratti
patent: 5725863 (1998-03-01), Daniels et al.
patent: 5849306 (1998-12-01), Sim et al.
patent: 5871977 (1999-02-01), Kubota et al.
patent: 5965141 (1999-10-01), Briles et al.
patent: 5976544 (1999-11-01), Charles et al.
patent: 6077693 (2000-06-01), Tang et al.
patent: 6565856 (2003-05-01), Skeiky et al.
patent: 6642023 (2003-11-01), Jackson et al.
patent: 6887843 (2005-05-01), Jackson et al.
patent: 2004/0037846 (2004-02-01), Jackson
patent: 2004/0137005 (2004-07-01), Jackson et al.
patent: 2005/0048557 (2005-03-01), Jackson et al.
patent: 2005/0281847 (2005-12-01), Berthet et al.
patent: 0818681 (1998-01-01), None
patent: WO 96/31236 (1996-10-01), None
patent: WO 98/10789 (1998-03-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 01/40474 (2001-06-01), None
patent: WO 02/08267 (2002-01-01), None
Rudinger et al, in “Peptide Hormones”, edited by Parsons, J.A., University Park Press, Jun. 1976, p. 1-6).
Burgess et al., The Journal of Cell Biology, 111:2129-2138, 1990.
Lazar et al., Molecular and Cellular Biology, 8(3): 1247-1252, 1988).
Jobling et al. (Mol. Microbiol. 1991, 5(7): 1755-67.
Bowie et al (Science, 1990, 257:1306-1310).
Herbert et al (The Dictionary of Immunology, Academic Press, 3rd Edition, London, 1985, pp. 58-59).
Birkelund et al., Infection & Immunity, 56(3):654-59, Mar. 1988.
Buenida et al., FEMS Microbiol. Lttrs., May 1, 1(1):113-119 (1997).
Caldwell, et al., Infec. Immun., 31(3):1161-1176 (1981).
Cerrone et al., Infec. Immun., 59(1):79-90 (1991).
Chen et al., Molecular Microbiology 11(3):501-507 (1994).
Li et al., PNAS 77(6):3211-14 (1980).
DeSa et al., Infection & Immunity, Dec., 63(12):4912-16 (1995).
Murdin et al., Infec. Immun., 63(3):1116-1121 (1995).
Murdin et al., Infec. Immun., 61(10):4406-4414 (1993).
Sexton et al., J. of Immunol., 152(4):1861-72 (1994).
Su et al., PNAS 93:11143-48 (1986).
Swanson et al., Infec. Immun., 38(2):502-507 (1990).
Wagar et al., Infec. Immun., 56(7):1678-1684 (1988).
Zhang et al., Cell, 69:861-869 (1992).
Herring et al., FEMS Microbiol Letts. 65:153-158 (1989).
Tan et al., Infect Immun. 58(9) 3101-3108 (1990).
Zhang et al., Nucleic Acids Res. 18(4):1061 (1990).
Stephens et al., J. Bacteriol 168:1277-82 (1986).
WO 95/12411 published May 11, 1995 by Sabara.
WO 99/31236 published Oct. 10, 1996 by Prieels.
Hiller et al., EST Database Accession No. R91549, Aug. 25, 1995.
Goodman, JW, Immunogenicity & Antigenicity, in Basic and Clinical Immunology, Ed., Stites & Terr, Appleton & Lange, Norwalk, CT, 1991, pp. 102-108.
Jenkins, FJ, Basic Method for the Detection of PCR produts, PCR Methods and Applications, Cold Spring Harbor Laboratory S77-S82, 1994.
Sibson, et al., WO94/01548, Jan. 20, 1994.
Amersdorfer, P., et al., “Molecular Characterization of Murine Humoral Immune Response to Botulinum Neurotoxin Type A Binding Domain as Assessed by Using Phage Antibody Libraries,”Infect. Immun.65:3743-3752, American Society For Microbiology (1997).
Barenkamp, S.J. and St. Geme III, J.W., “Identification of Surface-Exposed B-Cell Epitopes on High-Molecular-Weight Adhesion Proteins of NontypeableHaemophilus influenzae,” Infect. Immun.64:3032-3037, American Society For Microbiology (1996).
Batteiger, B.E., et al., “Species-, Serogroup-, and Serovar-Specific Epitopes Are Juxtaposed in Variable Sequence Region 4 of the Major Outer Membrane Proteins of SomeChlamydia trachomatisSerovars,”Infect. Immun.64:2839-2841, American Society For Microbiology (1996).
Baughn, R.E., et al., “Epitope Mapping of B-Cell Determinants on the 15-Kilodalton Lipoprotein ofTreponema pallidum(Tpp15) with Synthetic Peptides,”Infect. Immun.64:2457-2466, American Society For Microbiology (1996).
Brown, D.R., et al., “Identification and Characterization of a Neutralizing Monoclonal Antibody Against Botulinum Neurotoxin, Serotype F, Following Vaccination With Active Toxin,”Hybridoma16:447-456, Mary Ann Leibert, Inc. (1997).
Burnie, J.P., et al., “Defining Antibody Targets inStreptococcus oralisInfection,”Infect. Immun.64:1600-1608, American Society For Microbiology (1996).
Christiansen, G., et al., “Molecular biology of theChlamydia pneumoniaesurface,”Scand. J. Infect. Dis. Suppl.104:5-10, Blackwell Science, Ltd. (1997).
Cunningham, M.W., et al., “Molecular Analysis of Human Cardiac Myosin-Cross-Reactive B- and T-Cell Epitopes of the Group A Streptococcal M5 Protein,”Infect. Immun.65:3913-3923, American Society For Microbiology (1997).
Davies, D.R. and Cohen, G.H., “Interactions of protein antigens with antibodies,”Proc. Natl. Acad. Sci. USA 93:7-12, National Academy of Sciences (1996).
De Sa, C., “La protéine majeure de la membrane externe deChlamydia: structure et fonctions,”Vet. Res.27: 317-331, ZDP Sciences (1996).
Delvig, A.A., et al., “Immune responses to linear epitopes on the PorB protein ofNeisseria meningitidisin patients with systemic meningococcal disease,”Microbiol.142:2491-2498, Society for General Microbiology (1996).
Deslauriers, M., et al., “Identification of Murine Protective Epitopes on thePorphyromonas gingivalisFimbrillin Molecule,”Infect. Immun.64:434-440, American Society for Microbiology (1996).
Duim, B., et al., “Fine Mapping of Outer Membrane Protein P2 Antigenic Sites Which Vary During Persistent Infection byHaemophilus influenzae,” Infect. Immun.64:4673-4679, American Society For Microbiology (1996).
Fan, J. and Stephens, R.S., “Antigen Conformation Dependence ofChlamydia trachomatisInfectivity Neutralization,”J. Infect. Dis.176:713-721, University of Chicago Press (1997).
Ghadjari, A., et al., “Epitope mappingCandida albicansproteinase (SAP 2),”FEMS Immunol. Med. Microbiol.19:115-123, Elsevier Science (1997).
Janeway, C., et al.,Immunogenicity,., John Wiley & Sons, Inc., New York, NY, pp. 65-71 (1989).
Ji, Y., et al.,“Intranasal immunization of C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus ,”Infect. Immun.65: 2080-2087, American Society for Microbiology (1997).
Lainson, F.A., et al., “Characterization of epitopes involved in the neutralization ofPasteurella haemolyticaserotype A 1 leukotoxin,”Microbiol.142:2499-2507, Society for General Microbiology (1996).
Li, C.H., et al., “β-Endorphin Omission Analogs: Dissociation of Immunoreactivity from Other Biological Activities,” ,Proc. Natl. Acad. Sci. USA 77:3211-3214, National Academy of Sciences (1980).
Méchin, M., et al., “Identification of Surface-Exposed Linear B-Cell Epitopes of the Nonfimbrial Adhesin CS31A ofEscherichia coliby Using Overlapping Peptides and Antipeptide Antibodies,”Infect. Immun.64:3555-3564, American Society for Microbiology (1996).
Morris, G.E.,Methods in Molecular Biology, vol. 66:Epitope Mapping, Morris, G.E., ed., Humana Press ,Totowa, NJ (1996).
Oettinger, T., et al., “Characterization of the Delayed Type Hypersensitivity-Inducing Epitope of MPT64 fromMycobacterium tuberculosis,” Scand. J. Immunol.45:499-503, Blackwell Sciences, Ltd

Affiliated with

Also associated with

Rating

Chlamydia protein, gene sequence and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chlamydia protein, gene sequence and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia protein, gene sequence and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3986796